Ravindran Ankathil

Health Campus, Malaysia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Genetic architecture of Multiple Myeloma and its prognostic implications - An updated review.

Genetic architecture of Multiple Myeloma and its prognostic implications - An updated review.

Journal: The Malaysian journal of pathology

Published: December 28, 2024

A Favourable Outcome in a Congenital Leukaemia Patient With Unique Cytogenetic Abnormalities.

A Favourable Outcome in a Congenital Leukaemia Patient With Unique Cytogenetic Abnormalities.

Journal: Cureus

Published: September 27, 2024

Chromosome Translocation t(6; 14) With Different Phenotypes and Segregation Patterns: A Report of Two Cases.

Chromosome Translocation t(6; 14) With Different Phenotypes and Segregation Patterns: A Report of Two Cases.

Journal: Cureus

Published: August 29, 2024

Association of ABCG2 Polymorphisms on Triple Negative Breast Cancer (TNBC) Susceptibility Risk.

Association of ABCG2 Polymorphisms on Triple Negative Breast Cancer (TNBC) Susceptibility Risk.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: July 23, 2023

Karyotype patterns, clinical features, and parental ages of three predominant live born autosomal trisomies of Northeast Malaysia.

Karyotype patterns, clinical features, and parental ages of three predominant live born autosomal trisomies of Northeast Malaysia.

Journal: The Malaysian journal of pathology

Published: August 31, 2022

Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium.

Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium.

Journal: Hereditary cancer in clinical practice

Published: December 03, 2021

Down Regulated Expression Levels of miR-27b and miR-451a as a Potential Biomarker for Triple Negative Breast Cancer Patients Undergoing TAC Chemotherapy.

Down Regulated Expression Levels of miR-27b and miR-451a as a Potential Biomarker for Triple Negative Breast Cancer Patients Undergoing TAC Chemotherapy.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: November 22, 2021

Differential prognostic impact of stratified additional chromosome abnormalities on disease progression among Malaysian chronic myeloid leukemia patients undergoing treatment with imatinib mesylate.

Differential prognostic impact of stratified additional chromosome abnormalities on disease progression among Malaysian chronic myeloid leukemia patients undergoing treatment with imatinib mesylate.

Journal: Frontiers in oncology

Published: June 05, 2021

Genetic Association of CYP1B1 4326 C>G Polymorphism with Disease-Free Survival in TNBC Patients Undergoing TAC Chemotherapy Regimen.

Genetic Association of CYP1B1 4326 C>G Polymorphism with Disease-Free Survival in TNBC Patients Undergoing TAC Chemotherapy Regimen.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: February 08, 2021

Clinical implications of conventional cytogenetics, fluorescence in situ hybridization (FISH) and molecular testing in chronic myeloid leukaemia patients in the tyrosine kinase inhibitor era - A review.

Clinical implications of conventional cytogenetics, fluorescence in situ hybridization (FISH) and molecular testing in chronic myeloid leukaemia patients in the tyrosine kinase inhibitor era - A review.

Journal: The Malaysian journal of pathology

Published: December 28, 2020

Gene therapy: An updated overview on the promising success stories.

Gene therapy: An updated overview on the promising success stories.

Journal: The Malaysian journal of pathology

Published: August 30, 2020

Impact of Fas/Fasl Gene Polymorphisms on Susceptibility Risk and Imatinib Mesylate Treatment Response in Chronic Myeloid Leukaemia Patients.

Impact of Fas/Fasl Gene Polymorphisms on Susceptibility Risk and Imatinib Mesylate Treatment Response in Chronic Myeloid Leukaemia Patients.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: May 13, 2020

Showing 1-12 of 43

Last Updated: 09/26/2026